PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Danimer Scientific, Inc. (DNMR)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS2362721001
CUSIP236272100
SectorBasic Materials
IndustrySpecialty Chemicals

Highlights

Market Cap$124.52M
EPS-$1.42
Revenue (TTM)$51.06M
Gross Profit (TTM)$2.80M
EBITDA (TTM)-$94.79M
Year Range$0.60 - $4.59
Target Price$2.57
Short %23.77%
Short Ratio22.37

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Danimer Scientific, Inc.

Popular comparisons: DNMR vs. VOO

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Danimer Scientific, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-60.00%-40.00%-20.00%0.00%20.00%NovemberDecember2024FebruaryMarchApril
-55.21%
15.75%
DNMR (Danimer Scientific, Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Danimer Scientific, Inc. had a return of -23.61% year-to-date (YTD) and -80.95% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-23.61%6.12%
1 month-42.28%-1.08%
6 months-52.20%15.73%
1 year-80.95%22.34%
5 years (annualized)N/A11.82%
10 years (annualized)N/A10.53%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-37.45%110.03%-18.66%
20236.15%-30.92%-23.78%-6.42%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of DNMR is 9, indicating that it is in the bottom 9% of the market in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.

The Risk-Adjusted Performance Rank of DNMR is 99
Danimer Scientific, Inc.(DNMR)
The Sharpe Ratio Rank of DNMR is 1212Sharpe Ratio Rank
The Sortino Ratio Rank of DNMR is 66Sortino Ratio Rank
The Omega Ratio Rank of DNMR is 99Omega Ratio Rank
The Calmar Ratio Rank of DNMR is 66Calmar Ratio Rank
The Martin Ratio Rank of DNMR is 1010Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Danimer Scientific, Inc. (DNMR) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


DNMR
Sharpe ratio
The chart of Sharpe ratio for DNMR, currently valued at -0.80, compared to the broader market-2.00-1.000.001.002.003.00-0.80
Sortino ratio
The chart of Sortino ratio for DNMR, currently valued at -1.69, compared to the broader market-4.00-2.000.002.004.006.00-1.69
Omega ratio
The chart of Omega ratio for DNMR, currently valued at 0.82, compared to the broader market0.501.001.500.82
Calmar ratio
The chart of Calmar ratio for DNMR, currently valued at -0.82, compared to the broader market0.001.002.003.004.005.00-0.82
Martin ratio
The chart of Martin ratio for DNMR, currently valued at -1.38, compared to the broader market-10.000.0010.0020.0030.00-1.38
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.89, compared to the broader market-2.00-1.000.001.002.003.001.89
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.74, compared to the broader market-4.00-2.000.002.004.006.002.74
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.33, compared to the broader market0.501.001.501.33
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.43, compared to the broader market0.001.002.003.004.005.001.43
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 7.65, compared to the broader market-10.000.0010.0020.0030.007.65

Sharpe Ratio

The current Danimer Scientific, Inc. Sharpe ratio is -0.80. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2024FebruaryMarchApril
-0.80
1.89
DNMR (Danimer Scientific, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Danimer Scientific, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2024FebruaryMarchApril
-98.79%
-3.66%
DNMR (Danimer Scientific, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Danimer Scientific, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Danimer Scientific, Inc. was 99.05%, occurring on Feb 5, 2024. The portfolio has not yet recovered.

The current Danimer Scientific, Inc. drawdown is 98.79%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.05%Feb 11, 2021750Feb 5, 2024
-15%Jan 28, 20212Jan 29, 20215Feb 5, 20217
-9.09%Dec 29, 20204Jan 4, 20212Jan 6, 20216
-7.73%Oct 19, 20208Oct 28, 202021Nov 27, 202029
-6.84%Dec 8, 20202Dec 9, 20201Dec 10, 20203

Volatility

Volatility Chart

The current Danimer Scientific, Inc. volatility is 35.20%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%NovemberDecember2024FebruaryMarchApril
35.20%
3.44%
DNMR (Danimer Scientific, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Danimer Scientific, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items